0001593968-19-001037.txt : 20190503
0001593968-19-001037.hdr.sgml : 20190503
20190503160955
ACCESSION NUMBER: 0001593968-19-001037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190501
FILED AS OF DATE: 20190503
DATE AS OF CHANGE: 20190503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCLAUGHLIN KEVIN F
CENTRAL INDEX KEY: 0001214938
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35280
FILM NUMBER: 19796215
MAIL ADDRESS:
STREET 1: C/O ACCELERON PHARMA INC.
STREET 2: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vericel Corp
CENTRAL INDEX KEY: 0000887359
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943096597
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7349305555
MAIL ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC
DATE OF NAME CHANGE: 19960428
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2019-05-01
0000887359
Vericel Corp
VCEL
0001214938
MCLAUGHLIN KEVIN F
C/O VERICEL CORPORATION
64 SIDNEY STREET
CAMBRIDGE
MA
02139
true
false
false
false
Stock Option (right to buy)
16.62
2019-05-01
4
A
false
13125
0
A
2019-06-01
2029-05-01
Common Stock
13125
13125
D
Restricted Stock Unit
2019-05-01
4
A
false
1750
0
A
Common Stock
1750
1750
D
The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.
Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
These RSUs vest 100% on the earlier of May 1, 2020 or the date of the first Annual Meeting of Stockholders following May 1, 2019.
No expiration date for this type of award.
/s/ Dominick C. Colangelo, Attorney-in-Fact for Kevin McLaughlin
2019-05-03